Logo image of ALMKT.PA

MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Fundamental Analysis

EPA:ALMKT - Euronext Paris - Matif - FR0010609263 - Common Stock - Currency: EUR

0.0905  0 (-0.55%)

Fundamental Rating

2

Taking everything into account, ALMKT scores 2 out of 10 in our fundamental rating. ALMKT was compared to 53 industry peers in the Health Care Equipment & Supplies industry. ALMKT may be in some trouble as it scores bad on both profitability and health. ALMKT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALMKT has reported negative net income.
ALMKT had a negative operating cash flow in the past year.
In the past 5 years ALMKT always reported negative net income.
ALMKT had a negative operating cash flow in each of the past 5 years.
ALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

ALMKT has a Return On Assets of -20.54%. This is in the lower half of the industry: ALMKT underperforms 67.92% of its industry peers.
ALMKT has a better Return On Invested Capital (13.46%) than 94.34% of its industry peers.
Industry RankSector Rank
ROA -20.54%
ROE N/A
ROIC 13.46%
ROA(3y)-42.36%
ROA(5y)-50.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMKT.PA Yearly ROA, ROE, ROICALMKT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

1.3 Margins

The Operating Margin of ALMKT (11.75%) is better than 67.92% of its industry peers.
ALMKT has a Gross Margin of 33.62%. This is in the lower half of the industry: ALMKT underperforms 75.47% of its industry peers.
Industry RankSector Rank
OM 11.75%
PM (TTM) N/A
GM 33.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMKT.PA Yearly Profit, Operating, Gross MarginsALMKT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALMKT is creating value.
ALMKT has more shares outstanding than it did 1 year ago.
ALMKT has more shares outstanding than it did 5 years ago.
ALMKT has a better debt/assets ratio than last year.
ALMKT.PA Yearly Shares OutstandingALMKT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ALMKT.PA Yearly Total Debt VS Total AssetsALMKT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -1.54, we must say that ALMKT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.54, ALMKT is doing worse than 75.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.54
ROIC/WACC2.42
WACC5.56%
ALMKT.PA Yearly LT Debt VS Equity VS FCFALMKT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.94 indicates that ALMKT may have some problems paying its short term obligations.
The Current ratio of ALMKT (0.94) is worse than 77.36% of its industry peers.
ALMKT has a Quick Ratio of 0.94. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMKT's Quick ratio of 0.66 is on the low side compared to the rest of the industry. ALMKT is outperformed by 66.04% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.66
ALMKT.PA Yearly Current Assets VS Current LiabilitesALMKT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

6

3. Growth

3.1 Past

ALMKT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.76%, which is quite impressive.
The Revenue has grown by 40.11% in the past year. This is a very strong growth!
Measured over the past years, ALMKT shows a quite strong growth in Revenue. The Revenue has been growing by 9.16% on average per year.
EPS 1Y (TTM)69.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250.72%
Revenue 1Y (TTM)40.11%
Revenue growth 3Y17.08%
Revenue growth 5Y9.16%
Sales Q2Q%-43.2%

3.2 Future

Based on estimates for the next years, ALMKT will show a very strong growth in Earnings Per Share. The EPS will grow by 36.89% on average per year.
ALMKT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.60% yearly.
EPS Next Y56.52%
EPS Next 2Y32.7%
EPS Next 3Y36.89%
EPS Next 5YN/A
Revenue Next Year-20.42%
Revenue Next 2Y2.84%
Revenue Next 3Y13.6%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALMKT.PA Yearly Revenue VS EstimatesALMKT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M
ALMKT.PA Yearly EPS VS EstimatesALMKT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMKT. In the last year negative earnings were reported.
Also next year ALMKT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMKT.PA Price Earnings VS Forward Price EarningsALMKT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALMKT indicates a rather cheap valuation: ALMKT is cheaper than 88.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.15
ALMKT.PA Per share dataALMKT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as ALMKT's earnings are expected to grow with 36.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.7%
EPS Next 3Y36.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMKT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAUNA KEA TECHNOLOGIES

EPA:ALMKT (5/9/2025, 7:00:00 PM)

0.0905

0 (-0.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)10-02 2025-10-02
Inst Owners16.8%
Inst Owner ChangeN/A
Ins Owners0.91%
Ins Owner ChangeN/A
Market Cap5.85M
Analysts86.67
Price Target0.82 (806.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.56
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 10.15
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.16
BVpS-0.31
TBVpS-0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.54%
ROE N/A
ROCE 18.32%
ROIC 13.46%
ROICexc 31.17%
ROICexgc 77.27%
OM 11.75%
PM (TTM) N/A
GM 33.62%
FCFM N/A
ROA(3y)-42.36%
ROA(5y)-50.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.24
Cap/Depr 23.09%
Cap/Sales 3.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.66
Altman-Z -1.54
F-Score1
WACC5.56%
ROIC/WACC2.42
Cap/Depr(3y)29.78%
Cap/Depr(5y)57.62%
Cap/Sales(3y)6.6%
Cap/Sales(5y)10.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250.72%
EPS Next Y56.52%
EPS Next 2Y32.7%
EPS Next 3Y36.89%
EPS Next 5YN/A
Revenue 1Y (TTM)40.11%
Revenue growth 3Y17.08%
Revenue growth 5Y9.16%
Sales Q2Q%-43.2%
Revenue Next Year-20.42%
Revenue Next 2Y2.84%
Revenue Next 3Y13.6%
Revenue Next 5YN/A
EBIT growth 1Y113.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year59.66%
EBIT Next 3Y21.8%
EBIT Next 5YN/A
FCF growth 1Y30.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.24%
OCF growth 3YN/A
OCF growth 5YN/A